Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparisons of neurodegenerative disease biomarkers across different biological fluids from patients with Huntington’s disease

23 Jan 2025

Abstract excerpt

Fluid biomarkers play important roles in many aspects of neurodegenerative diseases, such as Huntington's disease (HD). However, a main question relates to how well levels of biomarkers measured in CSF are correlated with those measured in peripheral fluids, such as blood or saliva. In this study, we quantified levels of four neurodegenerative disease-related proteins, neurofilament light (NfL), total tau...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology
Share to Neurological disorders and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39849121
DOI: 10.1007/s00415-024-12785-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparisons of neurodegenerative disease biomarkers across different biological fluids from patients with Huntington’s diseasePMID 39849121Read ↗

Cerebrospinal Fluid Biomarkers for Huntington’s DiseaseSemantic proximity Read ↗

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s diseaseSemantic proximity Read ↗

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.Semantic proximity Read ↗

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic PopulationSemantic proximity Read ↗

Salivary levels of total huntingtin are elevated in Huntington’s disease patientsSemantic proximity Read ↗

Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF studySemantic proximity Read ↗

Fluid biomarkers in frontotemporal dementia: past, present and futureSemantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.Semantic proximity Read ↗

Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich AssaySemantic proximity Read ↗

Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.Semantic proximity Read ↗

Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.